United States · FDA National Drug Code directory
lithium carbonate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-545_f0c7a72e-0f38-6613-e053-2a95a90a612c
- Product NDC
- 31722-545
- Form
- CAPSULE
- Composition / generic term
- lithium carbonate
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20091215
- Source listing expiry
- 20261231
Source-listed ingredients
- LITHIUM CARBONATE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (31722-545-01) · 31722-545-01
- 30 CAPSULE in 1 BLISTER PACK (31722-545-03) · 31722-545-03
- 500 CAPSULE in 1 BOTTLE (31722-545-05) · 31722-545-05
- 1000 CAPSULE in 1 BOTTLE (31722-545-10) · 31722-545-10
- 30 CAPSULE in 1 BOTTLE (31722-545-30) · 31722-545-30
- 5000 CAPSULE in 1 BOTTLE (31722-545-50) · 31722-545-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →